EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Automated mRNA ‐Based Detection of ER , PR , HER2 , and Ki‐67 in Breast Cancer Tissue and Cytology Samples in Resource‐Limited Settings

Partha Basu iD, Anuradha Talukdar iD, Poulome Mukherjee, Richard Muwonge, Eric Lucas iD, Monoj Kumar Deka, Amanjit Bal, Upasana Gautam, Manish Rohilla iD, Baneet Bansal, Veenu Singla iD, Siddhant Khare iD und 4 weitere

Cancer Medicine · 2026

DOI: 10.1002/cam4.72359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Partha Basu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Ki-67 Antigen, Receptors, Estrogen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Centre International de Recherche sur le Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accurate detection of estrogen and progesterone receptors (ER/PR), HER2, and Ki‐67 is essential for molecular classification of breast cancer and in deciding upon tailored treatment. In many low‐ and middle‐income countries (LMICs), access to histopathology and immunohistochemistry (IHC) is limited. STRAT4, an automated RT‐qPCR assay performed on the widely available GeneXpert platform, offers a potential alternative. We evaluated the performance of STRAT4 on core biopsy, unstained smear of fine‐needle aspiration biopsy (FNAB‐US), and cellblock samples compared with conventional IHC in 178 histopathology‐confirmed breast cancer patients.

Methods

Matched core biopsy, cellblock, and FNAB‐US samples were analyzed using STRAT4. Concordance with IHC for ER, PR, HER2, and Ki‐67 was assessed using percentage agreement and kappa statistics. The effect of alternative d C t cut‐offs used in an earlier study was also examined. Molecular subtype classification derived from STRAT4 was compared with IHC‐based classification.

Results

Concordance between STRAT4 and IHC was high for ER across all sample types ( κ : 0.78–0.86). PR detection showed substantial agreement for core biopsies ( κ = 0.78) and cellblocks ( κ = 0.63), but only fair for FNAB‐US samples ( κ = 0.53). HER2 detection showed moderate agreement ( κ = 0.41–0.58), improving with modified cut‐offs ( κ = 0.57–0.66), especially for FNAB‐US. Ki‐67 concordance was low (agreement 58.9%–71.0%). Kappa values indicating agreement between molecular subtype classifications using STRAT4 on various samples and routine IHC were as follows: core biopsies = 0.60; cellblocks = 0.61; FNAB‐US samples = 0.45.

Conclusion

Detection of ER from FNAB‐US, cellblocks, and core biopsies using STRAT4 showed high concordance with IHC. However, the concordance was low to moderate for other markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesKi-67 AntigenReceptors, EstrogenReceptors, ProgesteroneRNA, MessengerHumansFemaleBiomarkers, TumorBiopsy, Fine-NeedleResource-Limited SettingsImmunohistochemistryMiddle AgedAdultBiopsy, Large-Core Needle

Stichwörter der Autor:innen

biomarkersbreast cancerfine needle aspiration biopsyimmunohistochemistrylow‐ and middle‐income countriesmRNA detection

Substanzen

Erb-b2 Receptor Tyrosine KinasesKi-67 AntigenReceptors, EstrogenReceptors, ProgesteroneRNA, MessengerBiomarkers, TumorERBB2 protein, human

Autor:innen und Institutionen

  • Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.
  • Cachar Cancer Hospital & Research Centre, Silchar, India.
  • Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Cytology & Gynaecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of General Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

ORCID-Profile: Partha Basu, Anuradha Talukdar, Eric Lucas, Manish Rohilla, Veenu Singla, Siddhant Khare, Andre Lopes Carvalho, Anita Gadgil, Radhika Srinivasan

Förderung

  • Centre International de Recherche sur le Cancer

Zitieren

APA

Basu, P., Talukdar, A., Mukherjee, P., Muwonge, R., Lucas, E., Deka, M. K., Bal, A., Gautam, U., Rohilla, M., Bansal, B., Singla, V., Khare, S., Carvalho, A. L., Gadgil, A., Kannan, R., & Srinivasan, R. (2026). Automated mRNA ‐Based Detection of ER , PR , HER2 , and Ki‐67 in Breast Cancer Tissue and Cytology Samples in Resource‐Limited Settings. Cancer Medicine. https://doi.org/10.1002/cam4.72359

Vancouver

Basu P, Talukdar A, Mukherjee P, Muwonge R, Lucas E, Deka MK, et al. Automated mRNA ‐Based Detection of ER , PR , HER2 , and Ki‐67 in Breast Cancer Tissue and Cytology Samples in Resource‐Limited Settings. Cancer Medicine. 2026. doi:10.1002/cam4.72359

BibTeX
@article{Basu2026,
  author = {Basu, Partha and Talukdar, Anuradha and Mukherjee, Poulome and Muwonge, Richard and Lucas, Eric and Deka, Monoj Kumar and Bal, Amanjit and Gautam, Upasana and Rohilla, Manish and Bansal, Baneet and Singla, Veenu and Khare, Siddhant and Carvalho, Andre Lopes and Gadgil, Anita and Kannan, Ravi and Srinivasan, Radhika},
  title = {Automated mRNA ‐Based Detection of ER , PR , HER2 , and Ki‐67 in Breast Cancer Tissue and Cytology Samples in Resource‐Limited Settings},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.72359}
}
Kostenlos starten →